Getinge AB
STO:GETI B
Getinge AB
Depreciation & Amortization
Getinge AB
Depreciation & Amortization Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Getinge AB
STO:GETI B
|
Depreciation & Amortization
-kr1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
||
Elekta AB (publ)
STO:EKTA B
|
Depreciation & Amortization
-kr1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
||
S
|
Surgical Science Sweden AB
STO:SUS
|
Depreciation & Amortization
-kr14.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CellaVision AB
STO:CEVI
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Arjo AB (publ)
STO:ARJO B
|
Depreciation & Amortization
-kr397m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
||
Q linea AB
STO:QLINEA
|
Depreciation & Amortization
-kr22.6m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
Getinge AB
Glance View
Getinge AB, rooted in the lush landscapes of Sweden, has steadily evolved into a global leader in the medical technology sector. The company began its journey by manufacturing traditional sterilizers over a century ago. Over time, Getinge has carefully navigated and adapted to the ever-changing dynamics of the healthcare industry, positioning itself squarely at the intersection of innovation and practicality. Today, Getinge specializes in a broad spectrum of medical equipment and systems, focusing on critical care, surgery, and infection prevention. This focus is intricately designed to cater to hospitals and healthcare facilities worldwide, ensuring that patients receive the highest standard of care during complex procedures and critical conditions. Revenue streams for Getinge are as diversified as its product portfolio, comprising equipment sales, service contracts, and consumables. The company’s product offerings range from sophisticated ventilators and state-of-the-art heart-lung machines, to efficient sterilization and surgical workflow products. Beyond simply selling devices, Getinge builds sustainable revenue through long-term service agreements and the sale of replacement parts and consumables, which are essential for the ongoing, optimal operation of its technologically advanced machinery. This strategic emphasis on combining cutting-edge product development with a robust support infrastructure underscores Getinge’s business model, ensuring loyalty and ongoing relationships with healthcare institutions globally.
See Also
What is Getinge AB's Depreciation & Amortization?
Depreciation & Amortization
-1B
SEK
Based on the financial report for Dec 31, 2023, Getinge AB's Depreciation & Amortization amounts to -1B SEK.
What is Getinge AB's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-1%
Over the last year, the Depreciation & Amortization growth was 3%. The average annual Depreciation & Amortization growth rates for Getinge AB have been 11% over the past three years , -1% over the past five years .